{"title":"癌症患者的口腔保健","authors":"Crispian Scully , Joel B. Epstein","doi":"10.1016/0964-1955(96)00037-1","DOIUrl":null,"url":null,"abstract":"<div><p>Orofacial complications are common after radiotherapy to the head and neck, and after chemo-therapy for malignant disease. Mucositis is the most frequent and often most distressing complication, but adverse reactions can affect all other orofacial tissues. This paper discusses the aetiopathogenesis and current means available for preventing, ameliorating and treating these complications, as well as indicating research directions.</p></div>","PeriodicalId":77118,"journal":{"name":"European journal of cancer. Part B, Oral oncology","volume":"32 5","pages":"Pages 281-292"},"PeriodicalIF":0.0000,"publicationDate":"1996-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0964-1955(96)00037-1","citationCount":"168","resultStr":"{\"title\":\"Oral health care for the cancer patient\",\"authors\":\"Crispian Scully , Joel B. Epstein\",\"doi\":\"10.1016/0964-1955(96)00037-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Orofacial complications are common after radiotherapy to the head and neck, and after chemo-therapy for malignant disease. Mucositis is the most frequent and often most distressing complication, but adverse reactions can affect all other orofacial tissues. This paper discusses the aetiopathogenesis and current means available for preventing, ameliorating and treating these complications, as well as indicating research directions.</p></div>\",\"PeriodicalId\":77118,\"journal\":{\"name\":\"European journal of cancer. Part B, Oral oncology\",\"volume\":\"32 5\",\"pages\":\"Pages 281-292\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0964-1955(96)00037-1\",\"citationCount\":\"168\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of cancer. Part B, Oral oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0964195596000371\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of cancer. Part B, Oral oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0964195596000371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Orofacial complications are common after radiotherapy to the head and neck, and after chemo-therapy for malignant disease. Mucositis is the most frequent and often most distressing complication, but adverse reactions can affect all other orofacial tissues. This paper discusses the aetiopathogenesis and current means available for preventing, ameliorating and treating these complications, as well as indicating research directions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
